STUB1 stabilizes sirtuin 6 via K63-linked ubiquitination to promote NRF2 deacetylation for enhanced ferroptosis resistance after spinal cord injury

Abstract

Background: Spinal cord injury (SCI) is a severe traumatic condition with limited treatments. Ferroptosis, an iron-dependent type of controlled cell death, participates in SCI pathology. Nonetheless, the molecular mechanisms governing ferroptosis after SCI remain incompletely understood. Therefore, this study aims to elucidate the regulatory role of SIRT6 in neuronal ferroptosis post-SCI, identify its upstream modulator and downstream target, and evaluate the therapeutic potential of targeting this pathway for functional recovery. Methods: Ferroptosis markers were assessed in SCI mouse models and primary neurons. Sirtuin 6 (SIRT6) expression was regulated via lentiviral vectors and adeno-associated viral vectors. Protein interactions were identified by immunoprecipitation coupled with mass spectrometry and co-immunoprecipitation. Ubiquitination assays were conducted using ubiquitin mutants. Nuclear transcription factor erythroid 2-related factor 2 knockout (NRF2-KO) mice were used for in vivo validation. Functional recovery was evaluated by Basso Mouse Scale score, rotarod test, footprint analysis, and electromyography. Results: SIRT6 expression was downregulated following SCI and during erastin-induced ferroptosis. SIRT6 overexpression inhibited ferroptosis and triggered functional recovery, while SIRT6 suppression exacerbated these effects. Mechanistically, SIRT6 interacted with and deacetylated NRF2, promoting its nuclear translocation and antioxidant gene activation. STIP1 homology and U-box containing protein 1 (STUB1) was identified as an upstream regulator that physically interacted with SIRT6 via its U-box domain. STUB1 stabilized SIRT6 by promoting K63-linked ubiquitination, protecting it from proteasomal degradation. STUB1 overexpression inhibited ferroptosis and improved functional recovery, effects that were abolished by SIRT6 knockdown or NRF2-KO. Conclusions: The STUB1/SIRT6/NRF2 axis represents a novel regulatory pathway that suppresses neuronal ferroptosis and promotes functional recovery post-SCI. Targeting this axis may offer a prospective therapeutic strategy for SCI.

Keywords

Spinal cord injury / STUB1/SIRT6/NRF2 / Ferroptosis / Neuron / Ubiquitination / Neuronal ferroptosis

References

[1] Eckert MJ, Martin MJ. Trauma: spinal cord injury. Surg Clin North Am 2017; 97:1031-45. https://doi.org/10.1016/j.suc.2017.06.008.

[2] Injury GBDTB, Spinal Cord Injury C. Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18:56-87. https://doi.org/10.1016/S1474-4422(18)30415-0.

[3] Hosseini SM, Borys B, Karimi-Abdolrezaee S. Neural stem cell therapies for spinal cord injury repair: an update on recent preclinical and clinical advances. Brain 2024; 147:766-93. https://doi.org/10.1093/brain/awad392.

[4] Jin Y, Song Y, Lin J, Liu T, Li G, Lai B, et al. Role of inflammation in neurological damage and regeneration following spinal cord injury and its therapeutic implications. Burns Trauma 2023; 11:tkac054. https://doi.org/10.1093/burnst/tkac054.

[5] Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 2022; 21:47. https://doi.org/10.1186/s12943-022-01530-y.

[6] Lei P, Walker T, Ayton S. Neuroferroptosis in health and diseases. Nat Rev Neurosci 2025; 26:497-511. https://doi.org/10.1038/s41583-025-00930-5.

[7] Bao Z, Liu Y, Chen B, Miao Z, Tu Y, Li C, et al. Prokineticin-2 prevents neuronal cell deaths in a model of traumatic brain injury. Nat Commun 2021; 12:4220. https://doi.org/10.1038/s41467-021-24469-y.

[8] Bhowmick S, Banerjee S, Shridhar V, Mondal S. Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance. Mol Cancer 2025; 24:161. https://doi.org/10.1186/s12943-025-02337-3.

[9] Rong Y, Fan J, Ji C, Wang Z, Ge X, Wang J, et al. USP11 regulates autophagy-dependent ferroptosis after spinal cord ischemia-reperfusion injury by deubiquitinating Beclin 1. Cell Death Differ 2022; 29:1164-75. https://doi.org/10.1038/s41418-021-00907-8.

[10] Dong H, Xia Y, Jin S, Xue C, Wang Y, Hu R, et al. Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11. Cell Death Dis 2021; 12:1027. https://doi.org/10.1038/s41419-021-04307-1.

[11] Ge H, Xue X, Xian J, Yuan L, Wang L, Zou Y, et al. Ferrostatin-1 alleviates white matter injury via decreasing ferroptosis following spinal cord injury. Mol Neurobiol 2022; 59:161-76. https://doi.org/10.1007/s12035-021-02571-y.

[12] Yao X, Zhang Y, Hao J, Duan HQ, Zhao CX, Sun C, et al. Deferoxamine promotes recovery of traumatic spinal cord injury by inhibiting ferroptosis. Neural Regen Res 2019; 14:532-41. https://doi.org/10.4103/1673-5374.245480.

[13] Ding YN, Wang HY, Chen XF, Tang X, Chen HZ. Roles of sirtuins in cardiovascular diseases: mechanisms and therapeutics. Circ Res 2025; 136:524-50. https://doi.org/10.1161/CIRCRESAHA.124.325440.

[14] Burtscher J, Denti V, Gostner JM, Weiss AKH, Strasser B, Hüfner K, et al. The interplay of NAD and hypoxic stress and its relevance for ageing. Ageing Res Rev 2025; 104:102646. https://doi.org/10.1016/j.arr.2024.102646.

[15] Kane AE, Sinclair DA. Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases. Circ Res 2018; 123:868-85. https://doi.org/10.1161/CIRCRESAHA.118.312498.

[16] Roichman A, Elhanati S, Aon MA, Abramovich I, di Francesco A, Shahar Y, et al. Restoration of energy homeostasis by SIRT6 extends healthy lifespan. Nat Commun 2021; 12:3208. https://doi.org/10.1038/s41467-021-23545-7.

[17] Matsuno H, Tsuchimine S, Fukuzato N, O’Hashi K, Kunugi H, Sohya K. Sirtuin 6 is a regulator of dendrite morphogenesis in rat hippocampal neurons. Neurochem Int 2021; 145:104959. https://doi.org/10.1016/j.neuint.2021.104959.

[18] Zhang W, Bai L, Xu W, Liu J, Chen Y, Lin W, et al. Sirt6 mono-ADP-ribosylates YY1 to promote dystrophin expression for neuromuscular transmission. Adv Sci (Weinh) 2024; 11:e2406390. https://doi.org/10.1002/advs.202406390.

[19] Zhang J, Li Y, Liu Q, Huang Y, Li R, Wu T, et al. Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells. Hepatology 2021; 73:1140-57. https://doi.org/10.1002/hep.31418.

[20] Li W, Feng W, Su X, Luo D, Li Z, Zhou Y, et al. SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via Runx2 in chronic kidney disease. J Clin Invest 2022; 132:e150051. https://doi.org/10.1172/JCI150051.

[21] Baker JR, Vuppusetty C, Colley T, Papaioannou AI, Fenwick P, Donnelly L, et al. Oxidative stress dependent microRNA-34a activation via PI3Kalpha reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells. Sci Rep 2016; 6:35871. https://doi.org/10.1038/srep35871.

[22] Pan H, Guan D, Liu X, Li J, Wang L, Wu J, et al. SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res 2016; 26:190-205. https://doi.org/10.1038/cr.2016.4.

[23] Rui T, Wang H, Li Q, Cheng Y, Gao Y, Fang X, et al. Deletion of ferritin H in neurons counteracts the protective effect of melatonin against traumatic brain injury-induced ferroptosis. J Pineal Res 2021; 70:e12704. https://doi.org/10.1111/jpi.12704.

[24] Wu Q, Gao C, Wang H, Zhang X, Li Q, Gu Z, et al. Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation. Int J Biochem Cell Biol 2018; 94:44-55. https://doi.org/10.1016/j.biocel.2017.11.007.

[25] Lee OH, Kim J, Kim JM, Lee H, Kim EH, Bae SK, et al. Decreased expression of sirtuin 6 is associated with release of high mobility group box-1 after cerebral ischemia. Biochem Biophys Res Commun 2013; 438:388-94. https://doi.org/10.1016/j.bbrc.2013.07.085.

[26] Palubinsky AM, Stankowski JN, Kale AC, Codreanu SG, Singer RJ, Liebler DC, et al. CHIP is an essential determinant of neuronal mitochondrial stress signaling. Antioxid Redox Signal 2015; 23:535-49. https://doi.org/10.1089/ars.2014.6102.

[27] Lizama BN, Palubinsky AM, Raveendran VA, Moore AM, Federspiel JD, Codreanu SG, et al. Neuronal preconditioning requires the mitophagic activity of C-terminus of HSC70-interacting protein. J Neurosci 2018; 38:6825-40. https://doi.org/10.1523/JNEUROSCI.0699-18.2018.

[28] Badhiwala JH, Wilson JR, Witiw CD, Harrop JS, Vaccaro AR, Aarabi B, et al. The influence of timing of surgical decompression for acute spinal cord injury: a pooled analysis of individual patient data. Lancet Neurol 2021; 20:117-26. https://doi.org/10.1016/S1474-4422(20)30406-3.

[29] Karsy M, Hawryluk G. Modern medical management of spinal cord injury. Curr Neurol Neurosci Rep 2019; 19:65. https://doi.org/10.1007/s11910-019-0984-1.

[30] Lu Y, Shang Z, Zhang W, Pang M, Hu X, Dai Y, et al. Global incidence and characteristics of spinal cord injury since 2000-2021: a systematic review and meta-analysis. BMC Med 2024; 22:285. https://doi.org/10.1186/s12916-024-03514-9.

[31] Lu Y, Shang Z, Zhang W, Hu X, Shen R, Zhang K, et al. Global, regional, and national burden of spinal cord injury from 1990 to 2021 and projections for 2050: a systematic analysis for the Global Burden of Disease 2021 study. Ageing Res Rev 2025; 103:102598. https://doi.org/10.1016/j.arr.2024.102598.

[32] Zhang Y, Yang S, Liu C, Han X, Gu X, Zhou S. Deciphering glial scar after spinal cord injury. Burns Trauma 2021; 9:tkab035. https://doi.org/10.1093/burnst/tkab035.

[33] Geng YQ, Qiu LN, Cheng YQ, Li JJ, Ma YL, Zhao CC, et al. Alleviating recombinant tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke via targeted delivery of a ferroptosis inhibitor. Adv Sci (Weinh) 2024; 11:e2309517. https://doi.org/10.1002/advs.202309517.

[34] Chen B, Shi G, Xu J, Zhang X, Zhu Y, Li L, et al. IL-23 promotes neuronal ferroptosis via IL-23R/STAT3 signaling after traumatic brain injury. Cell Commun Signal 2025; 23:317. https://doi.org/10.1186/s12964-025-02319-4.

[35] Tian Y, Wang F, Ma J, Huang W, Zhang X, du C, et al. Targeting ferroptosis and mitophagy with neutrophil-inspired nanozyme for Parkinson’s disease therapy. J Control Release 2025; 384:113950. https://doi.org/10.1016/j.jconrel.2025.113950.

[36] Streit WJ, Phan L, Bechmann I. Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease. Pharmacol Rev 2025; 77:100005. https://doi.org/10.1124/pharmrev.123.000823.

[37] Feng Z, Min L, Chen H, Deng W, Tan M, Liu H, et al. Iron overload in the motor cortex induces neuronal ferroptosis following spinal cord injury. Redox Biol 2021; 43:101984. https://doi.org/10.1016/j.redox.2021.101984.

[38] Chu B, Kon N, Chen D, Li T, Liu T, Jiang L, et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol 2019; 21:579-91. https://doi.org/10.1038/s41556-019-0305-6.

[39] Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 2019; 572:402-6. https://doi.org/10.1038/s41586-019-1426-6.

[40] Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, et al. A targetable CoQ-FSP1 axis drives ferroptosis-and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun 2022; 13:2206. https://doi.org/10.1038/s41467-022-29905-1.

[41] Yao F, Deng Y, Zhao Y, Mei Y, Zhang Y, Liu X, et al. A targetable LIFR-NF-kappaB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis. Nat Commun 2021; 12:7333. https://doi.org/10.1038/s41467-021-27452-9.

[42] Liu CM, Wang RY, Saijilafu JZX, Zhang BY, Zhou FQ. MicroRNA-138 and SIRT1 form a mutual negative feedback loop to regulate mammalian axon regeneration. Genes Dev 2013; 27:1473-83. https://doi.org/10.1101/gad.209619.112.

[43] Lee J, Kim Y, Liu T, Hwang YJ, Hyeon SJ, Im H, et al. SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer’s disease. Aging Cell 2018; 17:e12679. https://doi.org/10.1111/acel.12679.

[44] Wang Y, Yang JQ, Hong TT, Sun YH, Huang HL, Chen F, et al. RTN4B-mediated suppression of sirtuin 2 activity ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer’s disease mouse model. Aging Cell 2020; 19:e13194. https://doi.org/10.1111/acel.13194.

[45] Singh P, Hanson PS, Morris CM. Sirtuin-2 protects neural cells from oxidative stress and is elevated in neurodegeneration. Parkinsons Dis 2017; 2017:1-17. https://doi.org/10.1155/2017/2643587.

[46] Zhang W, Wan H, Feng G, Qu J, Wang J, Jing Y, et al. SIRT6 deficiency results in developmental retardation in cynomolgus monkeys. Nature 2018; 560:661-5. https://doi.org/10.1038/s41586-018-0437-z.

[47] Kanfi Y, Naiman S, Amir G, Peshti V, Zinman G, Nahum L, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012; 483:218-21. https://doi.org/10.1038/nature10815.

[48] Taylor JR, Wood JG, Mizerak E, Hinthorn S, Liu J, Finn M, et al. Sirt6 regulates lifespan in Drosophila melanogaster. Proc Natl Acad Sci USA 2022; 119:e2111176119. https://doi.org/10.1073/pnas.2111176119.

[49] Cai S, Fu S, Zhang W, Yuan X, Cheng Y, Fang J. SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer. Biochem Biophys Res Commun 2021; 577:158-64. https://doi.org/10.1016/j.bbrc.2021.08.080.

[50] Cadenas S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med 2018; 117:76-89. https://doi.org/10.1016/j.freeradbiomed.2018.01.024.

[51] Hayes JD, Dayalan Naidu S, Dinkova-Kostova AT. Regulating Nrf2 activity: ubiquitin ligases and signaling molecules in redox homeostasis. Trends Biochem Sci 2025; 50:179-205. https://doi.org/10.1016/j.tibs.2024.12.010.

[52] Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 2019; 23:101107. https://doi.org/10.1016/j.redox.2019.101107.

[53] Wang Y, Chen D, Xie H, Jia M, Sun X, Peng F, et al. AUF1 protects against ferroptosis to alleviate sepsis-induced acute lung injury by regulating NRF2 and ATF3. Cell Mol Life Sci 2022; 79:228. https://doi.org/10.1007/s00018-022-04248-8.

[54] Anandhan A, Dodson M, Shakya A, Chen J, Liu P, Wei Y, et al. NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv 2023; 9:eade9585. https://doi.org/10.1126/sciadv.ade9585.

[55] Xue X, Wang M, Cui J, Yang M, Ma L, Kang R, et al. Glutathione metabolism in ferroptosis and cancer therapy. Cancer Lett 2025; 621:217697. https://doi.org/10.1016/j.canlet.2025.217697.

[56] Xiang Y, Song X, Long D. Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases. Arch Toxicol 2024; 98:579-615. https://doi.org/10.1007/s00204-023-03660-8.

[57] Jiao F, Zhang Z, Hu H, Zhang Y, Xiong Y. SIRT6 activator UBCS039 inhibits thioacetamide-induced hepatic injury in vitro and in vivo. Front Pharmacol 2022; 13:837544. https://doi.org/10.3389/fphar.2022.837544.

[58] Zhang W, Wei R, Zhang L, Tan Y, Qian C. Sirtuin 6 protects the brain from cerebral ischemia/reperfusion injury through NRF2 activation. Neuroscience 2017; 366:95-104. https://doi.org/10.1016/j.neuroscience.2017.09.035.

[59] Gao F, Qian M, Liu G, Ao W, Dai D, Yin C. USP10 alleviates sepsis-induced acute kidney injury by regulating Sirt6-mediated Nrf2/ARE signaling pathway. J Inflamm (Lond) 2021; 18:25. https://doi.org/10.1186/s12950-021-00291-7.

[60] Zhao W, Gasterich N, Clarner T, Voelz C, Behrens V, Beyer C, et al. Astrocytic Nrf2 expression protects spinal cord from oxidative stress following spinal cord injury in a male mouse model. J Neuroinflammation 2022; 19:134. https://doi.org/10.1186/s12974-022-02491-1.

[61] Zhang S, Hu ZW, Mao CY, Shi CH, Xu YM. CHIP as a therapeutic target for neurological diseases. Cell Death Dis 2020; 11:727. https://doi.org/10.1038/s41419-020-02953-5.

[62] Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Höfeld J, et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 2001; 3:93-6. https://doi.org/10.1038/35050618.

[63] Murata S, Chiba T, Tanaka K. CHIP: a quality-control E3 ligase collaborating with molecular chaperones. Int J Biochem Cell Biol 2003; 35:572-8. https://doi.org/10.1016/s1357-2725(02)00394-1.

[64] Zhan S, Wang T, Ge W. Multiple functions of the E3 ubiquitin ligase CHIP in immunity. Int Rev Immunol 2017; 36:300-12. https://doi.org/10.1080/08830185.2017.1309528.

[65] Liu Y, Zhou Y, Zhang P, Li X, Duan C, Zhang C. CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma. Cell Death Differ 2021; 28:1026-40. https://doi.org/10.1038/s41418-020-00635-5.

[66] Li Y, Jin C, Shen M, Wang Z, Tan S, Chen A, et al. Iron regulatory protein 2 is required for artemether-mediated anti-hepatic fibrosis through ferroptosis pathway. Free Radic Biol Med 2020; 160:845-59. https://doi.org/10.1016/j.freeradbiomed.2020.09.008.